Dr. Courtney DiNardo, MD
Claim this profileM D Anderson Cancer Center
About Courtney DiNardo, MD
Education:
Earned an MD from the University of Michigan in 2006.
Completed a Master's in Science, Clinical Epidemiology (M.S.C.E.) at the University of Pennsylvania in 2012.
Experience:
Completed residency in Internal Medicine at the University of Pennsylvania Health System (2006-2009).
Undertook a Fellowship in Hematology and Medical Oncology at the same institution (2009-2012).
Serves as an Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center.
Focuses on clinical and research aspects of myeloid malignancies and the development of targeted therapeutic agents.
Area of expertise
Acute Myelogenous Leukemia
Courtney DiNardo, MD has run 16 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Acute Myeloid Leukemia
Courtney DiNardo, MD has run 16 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
The University Of Texas M.D. Anderson Cancer Center
Clinical Trials Courtney DiNardo, MD is currently running
Rezatapopt + Azacitidine
for Acute Myeloid Leukemia and Myelodysplastic Syndrome
A non-randomized phase Ib study of PC14586 (PMV therapeutics) in patients diagnosed with TP53Y220C-mutant myeloid malignancies, including AML and MDS.
Recruiting
1 award
Phase 1
6 criteria
MBG-453 + Azacitidine
for AML
To demonstrate the efficacy of targeted and tailored sequential therapy in patients with AML.
Recruiting
1 award
Phase 1 & 2
5 criteria
More about Courtney DiNardo, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 21 trials as a Principal Investigator · 10 Active Clinical Trials
Treatments Courtney DiNardo, MD has experience with
- Venetoclax
- Azacitidine
- Ivosidenib
- Cytarabine
- Enasidenib
- Decitabine
Breakdown of trials Courtney DiNardo, MD has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Chronic Myelomonocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Courtney DiNardo, MD specialize in?
Courtney DiNardo, MD focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved IDH positive patients, or patients who are TP53 positive.
Is Courtney DiNardo, MD currently recruiting for clinical trials?
Yes, Courtney DiNardo, MD is currently recruiting for 10 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Courtney DiNardo, MD has studied deeply?
Yes, Courtney DiNardo, MD has studied treatments such as Venetoclax, Azacitidine, Ivosidenib.
What is the best way to schedule an appointment with Courtney DiNardo, MD?
Apply for one of the trials that Courtney DiNardo, MD is conducting.
What is the office address of Courtney DiNardo, MD?
The office of Courtney DiNardo, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.